Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.

Publication ,  Journal Article
Kannanganat, S; Wyatt, LS; Gangadhara, S; Chamcha, V; Chea, LS; Kozlowski, PA; LaBranche, CC; Chennareddi, L; Lawson, B; Reddy, PBJ; Styles, TM ...
Published in: J Immunol
November 1, 2016

We tested, in rhesus macaques, the effects of a 500-fold range of an admixed recombinant modified vaccinia Ankara (MVA) expressing rhesus GM-CSF (MVA/GM-CSF) on the immunogenicity and protection elicited by an MVA/SIV macaque 239 vaccine. High doses of MVA/GM-CSF did not affect the levels of systemic envelope (Env)-specific Ab, but it did decrease the expression of the gut-homing receptor α4β7 on plasmacytoid dendritic cells (p < 0.01) and the magnitudes of Env-specific IgA (p = 0.01) and IgG (p < 0.05) in rectal secretions. The protective effect of the vaccine was evaluated using 12 weekly rectal challenges in rhesus macaques subgrouped by tripartite motif-containing protein 5α (TRIM5α) genotypes that are restrictive or permissive for infection by the challenge virus SIVsmE660. Eight of nine TRIM5α-restrictive animals receiving no or the lowest dose (1 × 105 PFU) of MVA/GM-CSF resisted all 12 challenges. In the comparable TRIM5α-permissive group, only 1 of 12 animals resisted all 12 challenges. In the TRIM5α-restrictive animals, but not in the TRIM5α-permissive animals, the number of challenges to infection directly correlated with the magnitudes of Env-specific rectal IgG (r = +0.6) and IgA (r = +0.6), the avidity of Env-specific serum IgG (r = +0.5), and Ab dependent cell-mediated virus inhibition (r = +0.6). Titers of neutralizing Ab did not correlate with protection. We conclude that 1) protection elicited by MVA/SIVmac239 is strongly dependent on the presence of TRIM5α restriction, 2) nonneutralizing Ab responses contribute to protection against SIVsmE660 in TRIM5α-restrictive animals, and 3) high doses of codelivered MVA/GM-CSF inhibit mucosal Ab responses and the protection elicited by MVA expressing noninfectious SIV macaque 239 virus-like particles.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Immunol

DOI

EISSN

1550-6606

Publication Date

November 1, 2016

Volume

197

Issue

9

Start / End Page

3586 / 3596

Location

United States

Related Subject Headings

  • Viral Vaccines
  • Viral Envelope Proteins
  • Vaccinia
  • Vaccines, DNA
  • Ubiquitin-Protein Ligases
  • Simian immunodeficiency virus
  • Simian Immunodeficiency Virus
  • Simian Acquired Immunodeficiency Syndrome
  • SAIDS Vaccines
  • Rectum
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kannanganat, S., Wyatt, L. S., Gangadhara, S., Chamcha, V., Chea, L. S., Kozlowski, P. A., … Amara, R. R. (2016). High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques. J Immunol, 197(9), 3586–3596. https://doi.org/10.4049/jimmunol.1600629
Kannanganat, Sunil, Linda S. Wyatt, Sailaja Gangadhara, Venkatesarlu Chamcha, Lynette S. Chea, Pamela A. Kozlowski, Celia C. LaBranche, et al. “High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques.J Immunol 197, no. 9 (November 1, 2016): 3586–96. https://doi.org/10.4049/jimmunol.1600629.
Kannanganat S, Wyatt LS, Gangadhara S, Chamcha V, Chea LS, Kozlowski PA, LaBranche CC, Chennareddi L, Lawson B, Reddy PBJ, Styles TM, Vanderford TH, Montefiori DC, Moss B, Robinson HL, Amara RR. High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques. J Immunol. 2016 Nov 1;197(9):3586–3596.

Published In

J Immunol

DOI

EISSN

1550-6606

Publication Date

November 1, 2016

Volume

197

Issue

9

Start / End Page

3586 / 3596

Location

United States

Related Subject Headings

  • Viral Vaccines
  • Viral Envelope Proteins
  • Vaccinia
  • Vaccines, DNA
  • Ubiquitin-Protein Ligases
  • Simian immunodeficiency virus
  • Simian Immunodeficiency Virus
  • Simian Acquired Immunodeficiency Syndrome
  • SAIDS Vaccines
  • Rectum